ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems

摘要

Drug product supply issues are becoming more frequent, whether they result from manufacturing difficulties or natural disasters that affect production, reductions in the supply of raw materials, voluntary recalls, manufacturer business decisions, FDA enforcement actions to ensure public safety, or stockpiling that leads to artificial shortages. Although it is impractical to prepare for every potential shortage, proper planning can minimize adverse effects on patient care and health-system costsrnand prevent problems from escalating into crises. The key to success will undoubtedly be found in the effectiveness of information gathering, teamwork to assess options, and communication with providers, patients, and administrators.